Broker Research
August 22, 2025 / 13:14 IST
Reported Standalone quarterly numbers for Akums Drugs Pharmaceuticals are:Net Sales at Rs 332.44 crore in June 2025 up 4.78% from Rs. 317.28 crore in June 2024.
Story continues below Advertisement
Quarterly Net Profit at Rs. 44.87 crore in June 2025 up 7.15% from Rs. 41.88 crore in June 2024.
EBITDA stands at Rs. 72.67 crore in June 2025 up 4.02% from Rs. 69.86 crore in June 2024.
Akums Drugs P EPS has decreased to Rs. 2.93 in June 2025 from Rs. 2.93 in June 2024.
Akums Drugs P shares closed at 481.80 on August 20, 2025 (NSE)
| Akums Drugs Pharmaceuticals | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'25 | Mar'25 | Jun'24 | | Net Sales/Income from operations | 332.44 | 328.75 | 317.28 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 332.44 | 328.75 | 317.28 | | EXPENDITURE | | Consumption of Raw Materials | 192.55 | 207.06 | 200.90 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 2.27 | 0.35 | -12.18 | | Power & Fuel | -- | -- | -- | | Employees Cost | 50.74 | 53.84 | 47.18 | | Depreciation | 10.25 | 10.09 | 9.38 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 42.77 | 49.78 | 37.69 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 33.86 | 7.63 | 34.30 | | Other Income | 28.56 | 32.05 | 26.18 | | P/L Before Int., Excpt. Items & Tax | 62.42 | 39.68 | 60.48 | | Interest | 2.91 | 2.63 | 6.21 | | P/L Before Exceptional Items & Tax | 59.51 | 37.06 | 54.27 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 59.51 | 37.06 | 54.27 | | Tax | 14.64 | 9.47 | 12.40 | | P/L After Tax from Ordinary Activities | 44.87 | 27.59 | 41.88 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 44.87 | 27.59 | 41.88 | | Equity Share Capital | 30.62 | 30.62 | 28.61 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 2.93 | 1.80 | 2.93 | | Diluted EPS | 2.93 | 1.80 | 2.93 | | EPS After Extra Ordinary | | Basic EPS | 2.93 | 1.80 | 2.93 | | Diluted EPS | 2.93 | 1.80 | 2.93 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
